ID   EB81-EBV
AC   CVCL_VU96
DR   Wikidata; Q93535585
RX   PubMed=14999777;
RX   PubMed=15657293;
CC   HLA typing: A*01:01,02:01; B*50,57; C*06 (PubMed=14999777).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VU97 ! EB81-MEL
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
RX   PubMed=14999777; DOI=10.1002/ijc.20038;
RA   Ma W.-B., Germeau C., Vigneron N., Maernoudt A.-S., Morel S., Boon T.,
RA   Coulie P.G., van den Eynde B.J.;
RT   "Two new tumor-specific antigenic peptides encoded by gene MAGE-C2 and
RT   presented to cytolytic T lymphocytes by HLA-A2.";
RL   Int. J. Cancer 109:698-702(2004).
//
RX   PubMed=15657293; DOI=10.1084/jem.20041379; PMCID=PMC2212796;
RA   Germeau C., Ma W.-B., Schiavetti F., Lurquin C., Henry E., Vigneron N.,
RA   Brasseur F., Lethe B., De Plaen E., Velu T.J., Boon T., Coulie P.G.;
RT   "High frequency of antitumor T cells in the blood of melanoma patients
RT   before and after vaccination with tumor antigens.";
RL   J. Exp. Med. 201:241-248(2005).
//